Cargando…
Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483339/ https://www.ncbi.nlm.nih.gov/pubmed/36794509 http://dx.doi.org/10.3324/haematol.2022.282627 |
| _version_ | 1785102353598251008 |
|---|---|
| author | Abdelmagid, Maymona G. Al-Kali, Aref Begna, Kebede H. Hogan, William J. Litzow, Mark R. Fleti, Farah Mangaonkar, Abhishek A. Patnaik, Mrinal S. Elliott, Michelle A. Alkhateeb, Hassan Shi, Min Howard, Matthew T. Reichard, Kaaren K. Ketterling, Rhett P. Shah, Mithun Pardanani, Animesh Gangat, Naseema Tefferi, Ayalew |
| author_facet | Abdelmagid, Maymona G. Al-Kali, Aref Begna, Kebede H. Hogan, William J. Litzow, Mark R. Fleti, Farah Mangaonkar, Abhishek A. Patnaik, Mrinal S. Elliott, Michelle A. Alkhateeb, Hassan Shi, Min Howard, Matthew T. Reichard, Kaaren K. Ketterling, Rhett P. Shah, Mithun Pardanani, Animesh Gangat, Naseema Tefferi, Ayalew |
| author_sort | Abdelmagid, Maymona G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10483339 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104833392023-09-08 Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival Abdelmagid, Maymona G. Al-Kali, Aref Begna, Kebede H. Hogan, William J. Litzow, Mark R. Fleti, Farah Mangaonkar, Abhishek A. Patnaik, Mrinal S. Elliott, Michelle A. Alkhateeb, Hassan Shi, Min Howard, Matthew T. Reichard, Kaaren K. Ketterling, Rhett P. Shah, Mithun Pardanani, Animesh Gangat, Naseema Tefferi, Ayalew Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-02-16 /pmc/articles/PMC10483339/ /pubmed/36794509 http://dx.doi.org/10.3324/haematol.2022.282627 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Abdelmagid, Maymona G. Al-Kali, Aref Begna, Kebede H. Hogan, William J. Litzow, Mark R. Fleti, Farah Mangaonkar, Abhishek A. Patnaik, Mrinal S. Elliott, Michelle A. Alkhateeb, Hassan Shi, Min Howard, Matthew T. Reichard, Kaaren K. Ketterling, Rhett P. Shah, Mithun Pardanani, Animesh Gangat, Naseema Tefferi, Ayalew Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival |
| title | Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival |
| title_full | Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival |
| title_fullStr | Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival |
| title_full_unstemmed | Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival |
| title_short | Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival |
| title_sort | blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483339/ https://www.ncbi.nlm.nih.gov/pubmed/36794509 http://dx.doi.org/10.3324/haematol.2022.282627 |
| work_keys_str_mv | AT abdelmagidmaymonag blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT alkaliaref blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT begnakebedeh blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT hoganwilliamj blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT litzowmarkr blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT fletifarah blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT mangaonkarabhisheka blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT patnaikmrinals blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT elliottmichellea blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT alkhateebhassan blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT shimin blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT howardmatthewt blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT reichardkaarenk blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT ketterlingrhettp blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT shahmithun blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT pardananianimesh blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT gangatnaseema blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival AT tefferiayalew blastphasemyeloproliferativeneoplasmwithpriorexposuretoruxolitinibcomparativeanalysisofmutationsandsurvival |